Salbair-Neb 1.25mg Transpules 2.5 ml

babies: it is safe to be used in children with the help of a spacer. lactating mothers: it is safe to use in a breastfeeding woman.
pregnancy: it is contraindicated in pregnancy. need to seek doctors’ advice driving: salbair neb inhaler may decrease alertness, affects vision and may cause dizziness and sleep.
do not drive if these symptoms occur. alcohol: avoid consumption of alcohol while taking a salbair neb inhaler as it causes severe dizziness.
kidney: there are no interactions found. liver: there are no interactions found.
.

vomiting dizziness pain tremors acute viral nasal pharyngitis sinusitis headache nervousness anxiety .

salbair neb is an antiasthmatic agent. it relaxes the muscles in the windpipe and broadens the windpipe.
this makes breathing easier resulting in decreased wheezing, coughing and breathlessness..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• needs to be taken as prescribed by the doctor • keep yourself well hydrated and maintain good oral hygiene while on medication • gargles should be used to rinse the mouth to avoid infections. • do not stop and continue the course as directed by your doctor • alcohol consumption needs to be avoided while on this medication as it may lead to severe dizziness • avoid driving or operating heavy machinery as it may lead to alertness, affects vision and may cause dizziness and sleep • in children inhaler must be used with the help of a spacer .

• salbair neb + isocarboxazid: concurrent use leads to the risk of an acute hypertensive episode • salbair neb + linezolid: concurrent use leads to the risk of an acute hypertensive episode • salbair neb + phenelzine: concurrent use leads to the risk of an acute hypertensive episode • salbair neb + tranylcypromine: concurrent use leads to the risk of an acute hypertensive episode serious • salbair neb + lefamulin: concurrent use leads to increase qtc interval • salbair neb + amitriptyline: concurrent use leads to increase or decrease effects of sympathomimetics • salbair neb + clomipramine: concurrent use leads to increase or decrease effects of sympathomimetics • salbair neb + doxepin: concurrent use leads to increase or decrease effects of sympathomimetics • salbair neb + maprotiline: concurrent use leads to increase or decreased effects of sympathomimetics .